Medical Journals

Orexin-induced Apoptosis: the Key Role of the Seven-transmembrane Domain Orexin Type 2 Receptor.

Authors:
  • Voisin Thierry
  • Firar Aadil El
  • Avondo Virgile
  • Laburthe Marc

From: Institut National de la Santé et de la Recherche Médicale, Unité 773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, BP 416, F-75018, Paris, France. tvoisin@bichat.inserm.fr

Endocrinology

  • Publish Date: Oct 2006
  • ISSN: 0013-7227
  • Volume: 147
  • Issue: 10
  • Pages: 4977-84
  • Medium: Print
  • Language: English
  • Citation (JAMA): Voisin Thierry, Firar Aadil El, Avondo Virgile, et al. Orexin-induced Apoptosis: the Key Role of the Seven-transmembrane Domain Orexin Type 2 Receptor.. Endocrinology Oct 2006;147:4977-84

Abstract

Orexin-A and orexin-B are regulatory peptides involved in the control of feeding, sleep-wakefulness, and exerting various endocrine and metabolic actions. Recently we demonstrated that orexins, acting at OX(1) receptor (OX(1)R), are proapoptotic peptides. The aim of this study was to investigate the role of the receptor subtype OX(2)R in the control of apoptosis. Orexins caused a caspase-dependent cell death by apoptosis and a drastic cell growth inhibition in Chinese hamster ovary cells transfected with OX(2)R cDNA. On addition of either orexin (10(-6) m) for 48 h, apoptosis was demonstrated by DNA fragmentation, chromatin condensation, annexin-V binding, and activation of caspase-3 and caspase-9. Orexins were active on apoptosis and cell growth inhibition in the range of concentrations between 10(-10) and 10(-5) m with an EC(50) of 5 x 10(-8) m peptides. No effect of orexins could be detected in parental Chinese hamster ovary cells. A rat pancreatic acinar cell line, AR42J, which expresses OX(2)R but not OX(1)R, also underwent growth suppression and apoptosis on treatment with orexins. Suppression of AR42J cell growth by 10(-6) m orexin was more than 75% after 24 h. Induction of annexin-V-labeled AR42J cell number was dose dependent, with EC(50) of 5.1 x 10(-8) m orexin-A and 9.8 x 10(-8) m orexin-B. The OX(2)R agonist [Ala (11), d-Leu (15)]orexin-B promoted effects on cell growth and apoptosis, which were similar to those elicited by orexins. The OX(1)R antagonist SB33487 did not alter orexin-induced inhibition of growth or orexin-induced stimulation of apoptosis in AR42J cells. For the first time, we provide functional and pharmacological evidence for a role of the OX(2)R in orexin-induced apoptosis.

Mesh Headings (Keywords): Animals, Apoptosis, CHO Cells, Caspases, Cell Line, Cricetinae, DNA, Complementary, Enzyme Inhibitors, Intracellular Signaling Peptides and Proteins, Neuropeptides, Pancreas, Rats, Receptors, G-Protein-Coupled, Receptors, Neuropeptide, Reverse Transcriptase Polymerase Chain Reaction


Check for Full Text / PubMed Unique Identifier (PMID): 16857748


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.